POC(Point-of-care) 혈당 측정 시장 규모, 점유율, 성장 분석 : 유형별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Point-of-care Glucose Testing Market size was valued at USD 3.58 Billion in 2024 and is poised to grow from USD 3.74 Billion in 2025 to USD 5.19 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The point-of-care glucose testing market is experiencing substantial growth, driven by the rising incidence of diabetes and the critical need for regular glucose monitoring. Portable testing devices enable immediate results, allowing both healthcare professionals and patients to conveniently monitor blood glucose levels at the point of care. Key benefits include timely insights for informed treatment decisions, improved patient outcomes, and overall cost reduction. However, challenges such as device accuracy, interferences, and high costs may limit accessibility for some users. Innovations in biosensor technology and integration with digital health platforms present opportunities for market expansion. Ultimately, this sector aims to empower individuals to manage diabetes effectively, enhancing global health outcomes and disease management strategies.

Top-down and bottom-up approaches were used to estimate and validate the size of the Point-of-care Glucose Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Point-of-care Glucose Testing Market Segments Analysis

Global Point-Of-Care Glucose Testing Market is segmented by type, application, end user and region. Based on type, the market is segmented into lancing devices and strips and blood-glucose meter. Based on application, the market is segmented into type-1 diabetes and type-2 diabetes. Based on end user, the market is segmented into hospitals and clinics, home care settings and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Point-of-care Glucose Testing Market

A significant catalyst for the growth of the point-of-care glucose testing market is the rising prevalence of diabetes worldwide. The escalating number of individuals diagnosed with diabetes creates a pressing need for consistent glucose monitoring to manage the condition effectively. As more people require regular testing to maintain their health, the demand for point-of-care testing devices continues to increase. This shifting landscape emphasizes the importance of accessible and efficient monitoring solutions, driving innovation and expansion within the market as healthcare systems strive to improve outcomes for those affected by this chronic illness.

Restraints in the Point-of-care Glucose Testing Market

The high cost associated with point-of-care glucose testing devices and their consumables poses a significant barrier to the expansion of the market. This affordability issue is particularly pronounced in developing regions where healthcare resources are scarce and disposable incomes are generally lower. As a result, the elevated prices of these testing devices can impede their broader acceptance, especially among low-income populations and healthcare institutions operating within tight budgetary limits. Consequently, this limitation can restrict the accessibility and utilization of point-of-care glucose testing, ultimately affecting overall market growth.

Market Trends of the Point-of-care Glucose Testing Market

The Point-of-care Glucose Testing market is witnessing a notable trend toward the integration of testing devices with digital health platforms and electronic health records. This cohesive approach facilitates seamless data transfer and real-time glucose level monitoring, thereby enhancing patient engagement in diabetes management. Patients can now track their glucose levels more effectively, while healthcare professionals gain access to comprehensive data for informed treatment decisions. This synergy between technology and healthcare not only improves the overall efficiency of diabetes care but also supports personalized medicine, ultimately driving better health outcomes and fostering a proactive approach to managing diabetes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Point-Of-Care Glucose Testing Market Size by Type & CAGR (2026-2033)

• Market Overview
• Lancing Devices and Strips
• Blood-Glucose Meter

Global Point-Of-Care Glucose Testing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Type-1 Diabetes
• Type-2 Diabetes

Global Point-Of-Care Glucose Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Home Care Settings
• Others

Global Point-Of-Care Glucose Testing Market Size & CAGR (2026-2033)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACON Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trividia Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTS Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics Holdings plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prodigy Diabetes Care, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Platinum Equity Advisors, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations